Dr. Rosenblatt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1605 Haskell St
Burlington, IA 52601Phone+1 319-752-9350
Education & Training
University of California (Irvine)Residency, Internal Medicine, 1972 - 1972
CHI Health ImmanuelInternship, Transitional Year, 1969 - 1970
University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1969
Publications & Presentations
PubMed
- 82 citationsQuantitative Phosphoproteomic Analysis of the STAT3/IL-6/HIF1α Signaling Network: An Initial Study in GSC11 Glioblastoma Stem CellsCarol L. Nilsson, Roslyn Dillon, Arugadoss Devakumar, Stone D.-H. Shi, Michael J. Greig
Journal of Proteome Research. 2010-01-04 - 98 citationsDe novo design of a redox-active minimal rubredoxin mimic.Vikas Nanda, Michael M. Rosenblatt, Artur Osyczka, Hidetoshi Kono, Zelleka Getahun
Journal of the American Chemical Society. 2005-04-05 - 99 citationsComputational de novo Design, and Characterization of an A2B2 Diiron ProteinChristopher M. Summa, Michael M. Rosenblatt, Jae-Kyoung Hong, James D. Lear, William F. DeGrado
Journal of Molecular Biology. 2002-08-30
Press Mentions
- New Marketplace Buzz Survey: Who’s to Blame for Drug Pricing, and How to Fix ItNovember 14th, 2019
5th Annual Chief Medical Officer Summit Announced by the Conference ForumMarch 21st, 2017
Grant Support
- DE Novo Design Of Type 3 Copper ProteinsNational Institute Of General Medical Sciences2001–2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
